Category
Cyclophosphamide
CAS Number
158401-52-6
Molecular Formula
C₇H₁₆ClN₂O₃P
Molecular Weight
242.64 g/mol
Synonym

 Cyclophosphamide Monochloro Impurity; 1,3,6,2-Oxadiazaphosphonine, 3-(2-chloroethyl)octahydro-2-hydroxy-, 2-oxide; 3-(2-chloroethyl)-2-hydroxy-1,3,6,2-oxadiazaphosphonane 2-oxide; 3-(2-Chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane; Cyclophosphamide Related Compound B (USP);Cyclophosphamide Monohydrate - Impurity D ; 
 

Keywords
Intermediates
Heterocycles
Phosphorylating and Phosphitylating Agents
Fine Chemicals
Impurities
Metabolites.
Pharmaceutical Standards
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Cyclophosphamide Related Compound B is identified with Cas no 158401-52-6 is a high-precision impurity standard used in analytical method development, impurity identification, and stability studies. It has a molecular formula C₇H₁₆ClN₂O₃P and a molecular weight of 242.64 g/mol, making it essential for advanced pharmaceutical analysis. Developed using state-of-the-art R&D infrastructure, it is supported with complete HPLC, MS, NMR, and IR characterization data, ensuring robust quality control and regulatory compliance. Manasa Life Sciences ensures full compliance with ICH, EMA, US FDA, USP, and EP standards by supplying high-quality Cyclophosphamide API and related reference materials. All products are supported with complete documentation, including Certificates of Analysis (COA), HPLC purity data, Mass Spectrometry (MS), NMR, IR characterization data, MSDS/SDS, and full traceability records. Strict adherence to GMP and GDP guidelines ensures consistent quality, reliability, and regulatory readiness for pharmaceutical research, quality assurance, and regulatory submissions.